![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 43, 33567-33573, October 27, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Physiology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900
Received for publication, July 5, 2000, and in revised form, July 27, 2000
| |
ABSTRACT |
|---|
|
|
|---|
dHAND and eHAND are basic helix-loop-helix
(bHLH) transcription factors expressed during embryogenesis and
are required for the proper development of cardiac and extraembryonic
tissues. HAND genes, like the myogenic bHLH genes, are classified as
class B bHLH genes, which are expressed in a tissue-restricted pattern and function by forming heterodimers with class A bHLH proteins. Myogenic bHLH genes are shown not to form homodimers efficiently, suggesting that their activity is dependent on their E-protein partners. To identify HIPs (HAND-interacting
proteins) that regulate the activity of the HAND genes, we
screened an 9.5-10.5-day-old mouse embryonic yeast two-hybrid library
with eHAND. Several HIPs held high sequence identity to eHAND,
indicating that eHAND could form and function as a homodimer. Based on
the high degree of amino acid identity between eHAND and dHAND, it is
possible that dHAND could also form homodimers and heterodimers with
eHAND. We show using yeast and mammalian two-hybrid assays as well as biochemical pull-down assays that eHAND and dHAND are capable of
forming both HAND homo- and heterodimers in vivo. To
investigate whether HAND genes form heterodimers with other
biologically relevant bHLH proteins, we tested and show HAND
heterodimerization with the recently identified Hairy-related
transcription factors, HRT1-3. This finding is exciting, because both
HRT and HAND genes are coexpressed in the developing heart and limb and
both have been implicated in establishing tissue boundaries and pattern
formation. Moreover, competition gel shift analysis demonstrates that
dHAND and eHAND can negatively regulate the DNA binding of MyoD/E12 heterodimers in a manner similar to MISTI and Id proteins, suggesting a
possible transcriptional inhibitory role for HAND genes. Taken together, these results show that dHAND and eHAND can form homo- and
heterodimer combinations with multiple bHLH partners and that this
broad dimerization profile reflects the mechanisms by which HAND genes
regulate transcription.
Members of the basic helix-loop-helix
(bHLH)1 superfamily of
transcription factors are expressed in a wide range of tissues during
development and play a major role in cell specification and
differentiation (1, 2). bHLH proteins bind DNA as either homo- or
heterodimers, such that the juxtaposition of the basic region of each
factor creates a combined DNA binding domain that recognizes 6-base
pair sequences termed an E box (3). Members of the bHLH
superfamily have been categorized into two main groups. The Class A
bHLH genes, which include the gene products of the E2A gene, E12 and
E47, and HEB, are defined by their ubiquitous expression in all tissues
and their ability to form homodimers as well as heterodimers with a
large range of other bHLH proteins (4, 5). In contrast, the class B
bHLH genes exhibit tissue-restricted expression and in the example the
myogenic bHLH genes, MyoD, myogenin, Myf5, and MRF4, do not form
homodimers efficiently (7), thus requiring the formation of
heterodimers with Class A bHLH genes (1, 6). This observation
established the paradigm that class B bHLH proteins form heterodimers
with class A bHLH factors to bind DNA and regulate transcription.
This paradigm has prompted numerous laboratories to use Class A bHLH
proteins as bait to identify novel Class B genes in yeast two-hybrid
screens (8). The HAND genes, dHAND (HAND2, Thing2, and Hed) and eHAND
(HAND1, Thing1, and Hxt) are class B bHLH transcription factors that
were cloned using Class A proteins as bait (9-12). Both HAND genes
exhibit tissue-restricted expression patterns that are partially
overlapping during development (9-12). dHAND is expressed within the
heart, neural crest, lateral mesoderm, deciduum, and limb bud of mouse
embryos (12). Although eHAND expression overlaps with that of dHAND in
the lateral mesoderm, neural crest, and outflow tract of the heart,
eHAND is expressed uniquely in extraembryonic mesoderm (9-11, 13). In
the developing ventricles, the HAND genes exhibit a sided expression
pattern where dHAND is expressed predominantly within the developing
right ventricle and eHAND is expressed predominantly within the left ventricle (9-11, 13, 14). The result of high levels of dHAND expression in the right ventricle, high levels of eHAND expression in
the left ventricle, and overlapping expression of d- and eHAND in the
outflow tract and at the boundary of both ventricles, is a gradient of
HAND transcription factors within the developing heart. In addition,
the expression of the HAND genes within the developing heart has been
shown to be essential for proper cardiac development because mice
harboring null mutations of both dHAND and eHAND show severe
developmental defects in both cardiac and extraembryonic mesoderm
(13-15). Taken together, these results demonstrate that the HAND genes
are critical for proper embryonic development, but the mechanism by
which these genes function has yet to be determined.
In our efforts to determine the functional role the HAND genes play in
development, we employed a yeast two-hybrid screen with full-length
eHAND as bait using an E9.5-10.5 embryonic library. Several HIPs
isolated from this screen were homologous to eHAND, suggesting that
eHAND could form homodimers. Given that the amino acid identity between
the bHLH regions of d- and eHAND is greater than 90%, we hypothesized
that dHAND could form homodimers and that dHAND and eHAND could form
heterodimers. To address these questions, we employed yeast and
mammalian two-hybrid analysis as well as biochemical pull-down
techniques to show that eHAND and dHAND are capable of forming
homodimer and heterodimers with each other. To determine whether d- and
eHAND were capable of forming heterodimers with other class B bHLH
factors, we tested heterodimerization of the HAND genes with the newly
described Hairy-related transcription factors, HRT1-3. HRTs are
coexpressed with HAND genes within the developing heart, limb buds, and
other mesodermally derived tissues and thus are biologically relevant HAND partners (16-18). Our data show that indeed HAND genes can form
heterodimers with the HRT genes, which is an intriguing finding because
both HRT and HAND genes have implicated roles in establishing tissue
boundaries and tissue patterning. Moreover, competitive gel shift
assays using an E box probe demonstrate that both dHAND and eHAND can
negatively regulate the DNA binding of MyoD/E12 heterodimers and thus
can regulate the transcription of other bHLH genes independent of
direct DNA binding. When considering the slightly overlapping sided
expression of the HAND genes in cardiac development, a complex
combinatorial array of interactions between d- and eHAND, E-proteins,
HRTs, and any unknown bHLH factors are possible. The dimerization
properties of the HAND genes suggests complex regulatory functions that
allow extremely fine transcriptional control of downstream target
genes. This multitude of dimeric complexes may facilitate gene
transcription via DNA binding or repress transcription by preventing
the dimerization and DNA binding of other bHLH factors.
Plasmids--
The plasmids pAS eHAND and VP16 eHAND were
generated using a 650-base pair PCR product of eHAND
beginning at the initiating methionine and ending at the
termination codon 5' primer 5'-GACGGCGAATTCATGAACCTCGTGGGCAGCTAC-3' and
3' primer 5'-GACGGCCCGGGTCACTGCAAATCGAGGTCGCG-3'. PCR conditions were 94 °C for 30 s, 55 °C for 45 s, and 72 °C for 1 min for 30 cycles. This PCR fragment was subcloned into pCR2.1
(Invitrogen) and excised as an EcoRI fragment for cloning
into pAS and VP16-3 vectors. pACT PAN1 is a HIP
(HAND-interacting protein) that
contains the bHLH region of PAN1 and was isolated from a yeast
two-hybrid screen of an E9.5-10.5 embryo library using pAS eHAND as
bait (19). WW3NEDD4 and 5.68VP16 were gifts from Dr. Guy James
(UTHSCSA). WW3NEDD4 is the third WW domain of NEDD4 cloned into pGBD
(20). 5.68VP16 is a nonspecific prey that was cloned from a yeast
two-hybrid screen using the WW domains 1 and 2 of MAGI-I (21). pAS
dHAND-bHLH was generated by restricting pSG424 dHAND-bHLH (a gift from
Dr. Brian Black, UCSF) with EcoRI and subcloning the
dHAND-bHLH insert into the EcoRI site of pAS. pACT HEIRI,
pCITE E12, and pSVE47VP16 were generous gifts from Dr. Brian Black (UCSF).
The plasmids pBIND, pBIND ID, pACT, pACT MyoD, and G5 Luciferase were
obtained from the Promega CheckMate mammalian two-hybrid system. pBIND
eHAND and pACT eHAND were constructed using the same EcoRI
insert from pAS eHAND, but the insert was digested out of VP16 eHAND as
a BamHI/NotI fragment. pACT dHAND was constructed by digesting the dHAND cDNA with BssHII, filling in the site with Klenow, ligating on a BamHI linker, and digesting with
BamHI and XbaI for subcloning. pGEX eHAND was
generated using the EcoRI fragment from VP16 eHAND. pGEX
dHAND was generated by taking an NcoI/XbaI dHAND
fragment from pCITE dHAND. pGEX 5.68 was a generous gift from Dr. Guy
James (UTHSCSA). PCRII Topo HRT 1, HRT2, and HRT3 were generous gifts
from Dr. Eric Olson (UTSWMC Dallas). These clones were digested with
EcoRV and BamHI, the inserts were cloned into
PCITE4B, and the resulting constructs were used to generate in
vitro labeled proteins.
Yeast Interaction Studies--
The yeast strain PJ69-4a (22) was
transformed with the various baits (pAS eHAND, pAS dHAND-bHLH, or
WW3NEDD4) and prey plasmids (VP16-3, eHANDVP16-3, 5.68VP16-3, pACT Heir
I, or pACT PAN1) as described previously using a lithium acetate
procedure (22). After transformation, the yeast were plated on
selective media that lacked tryptophan ( Biochemical Pull-down Assays--
The bacteria BL21 (Novagen)
were transfected with the constructs pGEX eHAND, pGEX dHAND, or pGEX
5.68 and then were induced to produce GST fusion proteins (23). The
proteins were isolated from bacteria using standard methods and bound
to glutathione-linked agarose beads (23). 35S-Labeled
in vitro transcribed and translated proteins for the bHLH
genes, eHAND, dHAND, HRT1, HRT2, HRT3, and E12, were made using TNT
rabbit reticulocyte lysate system (Promega) and were incubated with the
bound beads for18 h at 4 °C in binding buffer (0.3 M
sucrose, 1 mM EDTA, 10 mM Tris, pH 8.0, 0.15 M NaCl, 1% Triton X-100, 1 µg/ml leupeptin, 2 µg/ml
aprotinin, and 1 mM phenylmethylsulfonyl fluoride) (24).
The samples were then washed four times in wash buffer (binding buffer
with 0.6 M NaCl). The beads were boiled in loading buffer
and run through a 10% SDS-PAGE gel. Gels were then dried and exposed
to PhosphorImager screens or x-ray film.
Mammalian Two-hybrid Analysis--
Equal amounts (2 µg) of
pG5LUC, pBIND bait plasmid (pBIND, pBIND eHAND, or pBIND Id), and prey
plasmid (pACT, pACT eHAND, pACT dHAND, pACT MyoD or pSVE47VP16) were
transfected into COS cells seeded onto 3.5-cm dishes using
TransIT PanPak (Mirus Corp.) Lipofectin using the
manufacturer's protocol. Cells were harvested 48 h post
transfection, lysates were prepared, and luciferase assays were
performed using the Dual Luciferase reporter assay system (Promega) or
Bioluminescent reporter gene assay system (Tropix Inc.) following
recommended protocols. All samples were read on a Dynex MLX microtitre
plate Luminometer.
Gel Shifts--
The various bHLH proteins were in
vitro transcribed and translated using the Promega TNT system as
described in the manufacture's protocol. Oligonucleotides
corresponding to the E box from the muscle creatine kinase (MCK)
enhancer E box 5'-CCCCCCCAACACCTGCTGCCTGAGC-3' reported to bind
myogenic bHLH/E12 complexes were 5' end labeled and annealed with their
cold complement. 40 fmol of the labeled oligo were incubated
with 10 µl of unprogrammed reticulocyte lysate or a total of 10 µl
of programmed reticulocyte lysate with the indicated bHLH factor with
or without 100 fold cold oligo or mutant oligo
5'-GATTCCATTGGTGCTTGATTCCAGAG-3' as described (25) and then run through
a 5% polyacrylamide gel, dried, and exposed via PhosphorImager.
To identify HIPs that are potentially involved in the regulation
of HAND bioactivity, we screened an E9.5-10.5 embryo library using
full-length eHAND as bait. Several of these HIPs exhibited high levels
of LacZ activation and were sequenced. Surprisingly, one of these HIPs
held a 98% sequence identity to mouse eHAND between amino acids 44 and
217 that includes the entire bHLH domain (data not shown). Southern
blot analysis of PCR products generated from the 80 HIPs identified in
this screen showed an additional four clones to be mouse eHAND (data
not shown). The concept that eHAND could form an efficient homodimer
had never occurred to us because its expression pattern defined the
gene within class B of the bHLH superfamily, which are generally
thought not to form homodimers efficiently. To investigate this finding
in more detail, we constructed a full-length eHANDVP16 fusion to
determine whether full-length eHAND could form homodimers in yeast.
Concurrently, we looked at the ability of eHAND to form heterodimers
with the HLH protein Heir I, the mouse E-protein PAN1, and the bHLH
domain of dHAND. As expected from our initial findings, eHAND failed to
rescue yeast plated on quadruple dropout medium when transfected with
our empty VP16-3 containing prey construct or when transfected with
irrelevant prey clone 5.68 (Fig.
1A).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Trp) and leucine (
Leu) and
media that lacked tryptophan, leucine, histidine (
His), and adenine
(
Ade) and were grown at 30 °C as described (22). Yeast grown on
the
Trp/
Leu plates was then inoculated into liquid cultures in
Trp/
Leu medium and grown at 30 °C, and protein lysates from
these yeast were prepared and used in liquid
-galactosidase analysis
as described previously (22).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Galactosidase
activity confirms that no significant interaction occurs between eHAND and VP16 or with clone 5.68 (Fig. 1B). We also observed no
significant interaction by growth or
-galactosidase analysis of
eHAND with the HLH protein HEIR1. As expected, eHAND and PAN1 rescues
growth of yeast plated on quadruple dropout medium and shows 25-fold increase in activation of
-galactosidase activity (Fig.
1B).

View larger version (43K):
[in a new window]
Fig. 1.
Dimerization properties of HAND genes using
yeast two-hybrid analysis. A, growth assay shows
patched yeast transformations containing the various bait plasmids
listed on right pAS eHAND, pAS dHAND-bHLH, and WW-3NEDD4. The various
preys listed at top VP16-3, pACT HEIRI (ID1), eHANDVP16-3, pACT
PAN1 (E12), and 5.68VP16-3 onto plates lacking Trp and Leu
(
Trp,
Leu) and plates lacking Trp, Leu, His and Ade
(
Trp,
Leu,
His,
Ade). Only protein pairs that
directly interact will rescue yeast growth on the latter medium.
B, liquid
-galactosidase assays showing strength of the
protein-protein interactions. At least four independent transformations
were used for each interaction pair. Data are expressed as fold
activation with pAS eHAND/VP16-3 activity equal to 1.0. Error
bars denote standard error.
The nonspecific control bait containing the WW 3 domain of NEDD4
(WW3NEDD4) did not rescue significantly yeast plated on quadruple drop
out medium when cotransformed with eHANDVP16 or any of our other preys
and only accounted for a slight increase in
-galactosidase activity
over control when cotransformed with eHAND (Fig. 1). Full-length eHAND
transfected with itself, rescued yeast growth, and produced a more than
70-fold activation of
-galactosidase activity over control (Fig. 1).
As expected, we observe yeast rescue when eHAND is cotransfected with
the bHLH of dHAND. The HAND proteins share a high amino acid identity
within their bHLH domains and growth rescue and a 25-fold increase in
-galactosidase activity for the HAND heterodimer are similar to
results obtained with PAN1 (Fig. 1). Moreover, because only the bHLH of
dHAND was used in this assay, it indicates that the interactions
observed between d- and eHAND and e- and eHAND are likely to be through the bHLH domain. Although these results are suggestive that the HAND
genes are capable of forming homo- and heterodimers with each other, it
is not clear whether these interactions occur in a nonyeast system. To
address this question, we used a biochemical pull-down approach to
determine whether the dimerization properties of d- and eHAND observed
in yeast would occur in an in vitro system.
To demonstrate the ability of the HAND genes to form homo- and
heterodimers in a nonyeast system, we employed a pull-down assay using
a bacterially expressed GST fusion proteins of dHAND and eHAND that
were immobilized onto glutathione-linked agarose beads and
performed co-incubations with 35S-labeled in
vitro transcribed and translated proteins. Co-incubations were
then washed, and all protein retained on the beads was separated by
SDS-PAGE and detected by autoradiography or PhosphorImager exposure
(Fig. 2). As a control, the irrelevant
bait 5.68 was constructed as a GST fusion to ensure that interactions
observed are specific. Completely consistent with the yeast two-hybrid results, both dHAND and eHAND are retained on the GSTeHAND beads, indicating that the eHAND can form homo- and dHAND/eHAND heterodimers. The lack of retention of the radiolabeled d- and eHAND with an equal
amount of GST5.68 protein shows that interaction with these bHLH
factors is occurring specifically. (Fig. 2). When GSTdHAND linked beads
were incubated with the radiolabeled proteins, results similar to those
obtained with eHAND were observed (Fig. 2). As expected, GSTdHAND
pulled down dHAND, eHAND, and E12, which demonstrates that full-length
dHAND can form homodimers and heterodimers with eHAND and E12 (Fig. 2).
No significant retention of the radiolabeled proteins with GST5.68
occurred consistent with the yeast two-hybrid results (Fig. 2). Taken
together, the yeast two-hybrid results and biochemical pull-down
results strongly suggest that the bHLH domains of both d- and eHAND
have dimerization properties that allow for efficient homodimer
formation and the formation of efficient dHAND/eHAND heterodimers.
|
To determine whether HAND genes could interact in vivo, we
looked at the ability of eHAND to homo/heterodimerize within a mammalian cell using a mammalian two-hybrid assay. Bait plasmids for
eHAND and Id were used against a panel of preys in COS cells (Fig.
3). When the empty bait plasmid pBIND was
cotransfected with our series of prey plasmids, no significant
luciferase activity is observed (Fig. 3). Analysis of pBIND Id shows no
significant interaction with empty prey plasmid; however, a strong
activation of the luciferase reporter is seen when the Id bait is
cotransfected with pSVE47VP16 (7.5-fold) and pACT MyoD (9.0-fold) (Fig.
3). These results confirm previous findings that Id can interact with both of these factors and confirms that our interaction assay is
working (Fig. 2). Interaction of Id with eHAND and dHAND, however, showed background levels of luciferase activity confirming our yeast
two-hybrid results, suggesting that HAND genes do not interact with Id
to any significant degree (Fig. 3). When pBIND eHAND is cotransfected
with the empty prey vector pACT in our mammalian two-hybrid assay basal
levels of luciferase activity are observed (Fig. 3). In agreement with
our yeast and pull-down data, eHAND shows strong interaction when
cotransfected with pSVE47VP16, further confirming the ability of the
HAND genes to form heterodimers with the Class A family of bHLH genes.
(Fig. 3). When pBIND eHAND is co transfected with pACT eHAND or pACT
dHAND, we observe a significant increase in luciferase activity,
indicating that HAND homodimers and heterodimers can form efficiently
within mammalian cells (Fig. 3). Surprisingly, eHAND also showed a
noticeable increase in luciferase activity when cotransfected with pACT
MyoD (Fig. 3). The biological significance of this interaction is
unclear as eHAND and MyoD are not coexpressed during development;
however, the fact that eHAND can heterodimerize with another non-HAND
Class B bHLH factor suggests that HAND genes may regulate transcription by dimerizing with both class A and class B bHLH partners.
|
The observation that eHAND could form heterodimers with MyoD suggested
to us that HAND genes might have a wide range of dimerization partners
such that any coexpressed bHLH gene could potentially be a biologically
important HAND partner. Recently the HRT family of bHLH transcription
factors was identified, and HRT1 and HRT2 were shown to be expressed
within the early stages of the developing heart concurrent with both d-
and eHAND as well as within the developing limb (16-18). To look at
interaction, we performed GST pull downs with all three HRT factors
(Fig. 4). Results show that both GSTdHAND
and GSTeHAND retain significant amounts of radiolabeled HRT1, 2, and 3 when compared with levels of pulled-down HRT proteins observed with GST
or GST 5.68 beads, indicating efficient heterodimerization. Yeast
two-hybrid interactions confirm these observations (data not shown).
Taken together these results suggest that d- and eHAND can dimerize
with HRT factors and thus could effect transcription by directly
binding DNA in an HRT/HAND complex.
|
To examine the DNA binding properties of the HAND homodimers and
heterodimers, gel mobility shift assays were performed using double-stranded oligonucleotides containing an E box sequence that was
reported to bind eHAND/E12 using in vitro transcribed and
translated proteins (10). Results of these experiments recapitulated previously published results showing no HAND homodimer binding (data
not shown and Ref. 10). Given the heterodimerization of MyoD with
eHAND, we wanted to determine whether HAND dimerization could
negatively regulate MyoD/E12 DNA binding by titration of both E12 and
MyoD (Fig. 5). In this experiment,
in vitro transcribed and translated MyoD and E12 were
incubated with an E box sequence from the MCK enhancer previously shown
to bind this heterodimer (3). As expected MyoD/E12 complexes shifted
the migration of the labeled oligo, and this migration was inhibited by
the addition of excess cold oligo but not by the addition of a mutant
oligo that did not contain an E box (Fig. 5). Interestingly, addition of an equal amount of either eHAND or dHAND reduced the intensity of
the shifted MyoD/E12 complex showing a disruption of DNA binding (Fig.
5). Clearly in light of the mammalian two-hybrid results showing
MyoD/eHAND and E12/eHAND dimerization, the reduction of MyoD/E12 bound
to DNA is a result of dHAND and eHAND directly competing for
dimerization with both of these factors. Thus, HAND genes may act as
negative regulators of certain class A and class B bHLH genes in a
manner analogous to MISTI and Id family members.
|
| |
DISCUSSION |
|---|
|
|
|---|
In our efforts to find novel HIPs that interact with eHAND using the yeast two-hybrid system, we have uncovered the ability of eHAND and dHAND to form homodimers and heterodimers in vivo. This is an important finding because HAND genes, based on expression patterns and their initial isolation in yeast two-hybrid screens using E12 as bait, have been assumed to be biologically active only when dimerized with E-proteins. Unlike the myogenic bHLH genes, HAND genes are fully capable of forming homodimers and heterodimers with themselves in mammalian cells, suggesting that the various dimeric forms of the HAND genes can control the transcription of a diverse set of presently unknown downstream genes. The skeletal muscle bHLH gene MISTI has been shown to form homodimers and heterodimers with MyoD. (26). The MyoD/MISTI heterodimer is thought to form an inactive complex, blocking MyoD from forming E-protein heterodimers and thus inhibiting its activity. Our data show that HAND genes can function in the same manner as MISTI, and although HAND/MyoD interaction appears to be biologically irrelevant, it does strongly suggest that HAND genes could sequester yet to be discovered, coexpressed bHLH factors by a similar mechanisms.
The HRTs (also known as HESRs and HEYs) are expressed within the somatic mesoderm, central nervous system, kidney, and nasal epithelium and like the Hairy and Enhancer of Split (HES) bHLH factors, HRTs have been shown to depend on notch signaling (16-18). HRT1 and HRT2 are also coexpressed with the HAND genes during both limb and cardiac development. Members of the HES family of bHLH factors repress transcription via binding a cis-acting element termed a N box and are thought to establish boundaries of expression within the tissue in which they are expressed. Because HRTs respond to the same signaling pathway as HES factors, these genes are thought to play a similar biological role (16, 17). Very recently expression studies of dHAND within the developing limbs of mice, chickens, and fish show that dHAND plays an important role in limb anterior-posterior patterning (27-29). The finding that HAND genes play a direct role in anterior-posterior patterning taken together with our data showing that HAND genes can interact with HRT genes, which are postulated to establish discrete boundaries of gene expression that set up embryonic patterning, strongly suggest that HAND and HRT gene function in controlling anterior-posterior patterning may be through heterodimerization and possibly independent of E protein dimerization.
The ability of E proteins to form heterodimers with class B genes established the paradigm of how these ubiquitously expressed genes play a role in tissue-specific transcription. Myogenic bHLH family members that are expressed exclusively in skeletal muscle give the E proteins their specificity to implement skeletal muscle specification and differentiation. HAND genes are expressed within heart, neural crest, lateral, and extraembryonic mesoderm, developing sympathetic nerves and maternally derived deciduum. When considering this complex expression profile, it is difficult to imagine how these genes could control specific gene expression in these diverse tissues solely by heterodimerization with E proteins. It has been recently reported that E12/E47 is not expressed within trophoblast giant cells, a cell type that has been shown to require eHAND for proper development (13, 15, 30). Thus, eHAND homodimers and/or an eHAND heterodimer with an unidentified bHLH protein regulate transcription in an E-protein independent environment. The observation that d and eHAND can interact with MyoD and HRTs suggests that HAND genes are not limited in their choice of dimeric partners. Therefore, it is likely that transcription of HAND-regulated genes within different tissues as well as affinity of DNA binding of cis-acting targets may be mediated by the bHLH partner, as is the case with E proteins.
Speculation on the role of HAND dimerization in the developing heart
becomes extremely compelling. Most interesting the sided expression of
dHAND in the right ventricle and eHAND in the left ventricle represents
an anterior-posterior expression that is made left-right through
cardiac looping (31). In light of the role of dHAND in the developing
limb, it suggests that HAND genes may play a role in heart patterning.
dHAND is expressed in the developing right ventricle and eHAND is
expressed in the developing left ventricle and with both genes being
coexpressed at the ventricle boundary and within the outflow tract, a
transcription factor gradient is formed (Fig.
6). dHAND homodimers would form
preferentially within the right ventricle, eHAND homodimers within the
left ventricle, and the boundary of the developing ventricles and
outflow tract would have a mixture of dHAND and eHAND allowing for
dHAND/eHAND heterodimers (Fig. 6). Considering the ubiquitous
expression of E proteins within the heart, as well as HRT factors and
yet to be discovered cardiac bHLH factors, an extremely diverse
population of HAND transcriptional dimers is possible.
|
The ability of HAND proteins to form homo- and heterodimers with themselves and other class B bHLH factors allows for both direct transcriptional activation/repression via DNA binding and the negative regulation of itself and other bHLH factors via the formation of nonbinding dimer complexes. Recently, eHAND was shown to inhibit the DNA binding of MASH2 to the MCK E box by competing with MASH2 for E12 (30). In biochemical pull-down analysis, we show that eHAND can heterodimerize with MASH1 (unpublished results). In light of this data and interaction of eHAND with MyoD and the HRTs, it is possible that eHAND can heterodimerize with MASH2, and thus the reduction of DNA binding of the MASH2/E12 complex is a dual competition of eHAND for both bHLH factors. This type of negative regulation is observed in the Id family of HLH genes (32). The Id HLH proteins lack a basic region that is used to contact DNA and can form heterodimers with E proteins locking E12/E47 in inactive complexes. When considering the variations in gene expression and protein modifications such as phosphorylation that can alter protein-protein interactions, a resulting shift of dimerization choices of the HAND genes may represent the mechanism by which these proteins regulate function.
Although reports on the dHAND and eHAND knockout mice show
down-regulation of several genes, only a report on the regulation of
the adenylosuccinate synthetase I gene shows direct regulation by dHAND
or eHAND, and the exact cis-acting elements within the adenylosuccinate synthetase gene promoter that respond to HAND activation have yet to be identified (33). bHLH genes have been shown
to bind to either E box or N box sequences, but it has not been
established whether other sequences can be utilized for DNA binding. In
detailed analysis of the DNA binding characteristics of the myogenic
bHLH genes and E-proteins using binding site selection protocols, it
has been established that each member of the bHLH dimer recognizes a
specific half-site within the E box and that different combinations of
these factors selectively bind different E boxes (34, 35). Casting
experiments done on eHAND show that eHAND/E12 heterodimers bind a
degenerate E box NNTCTG and that eHAND homodimers can not bind this
sequence (10). Because of the lack of any cis-acting
elements known to be transcriptionally regulated by d- or eHAND, the
question of whether HAND homodimers, heterodimers, and/or
HAND/E-protein heterodimers can regulate expression remains unanswered.
In the previous DNA binding analysis, eHAND was combined with an
E-protein in the casting procedure. DNA binding sequences for HAND
homodimers and E-protein-independent heterodimers casting experiments
will need to be performed to determine whether any HAND dimer pair has
the ability to bind DNA. It is possible that HAND homodimers and
dHAND/eHAND heterodimers recognize a non-E box DNA target sequence.
This situation is seen with the bHLH factor HES-1, which does not bind
efficiently to an E box but recognizes a CACNAG motif termed a N box
(32, 36). Interestingly eHAND, like HES-1, contains a proline within
its basic domain that is atypical for bHLH family members. However, we
do not see DNA binding of eHAND to oligonucleotides containing N box
sequences with or without E12 (data not shown). Taken together our
results show that, unlike most class B bHLH factors, eHAND and dHAND
have expanded dimerization specificity that allows them to form a
variety of dimeric complexes in vivo. This observation suggests that HAND genes can function to negatively regulate themselves as well as other bHLH proteins by directly competing for bHLH partners.
By forming homo- and heterodimers, HAND genes can alter their own DNA
binding recognition and the DNA binding properties of other bHLH genes
revealing a complex mechanism for HAND gene regulation of biological function.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Tania Fernandez, Kunal Patel, and Cedric Wheelock for excellent technical assistance, Drs. G. James, B. Black, and E. Olson for generosity with reagents Drs. M. Steinhelper, B. Black, A. Rawls, and J. Wilson-Rawls for helpful comments and review of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the American Heart Association and by National Institutes of Health Grant R01 HLA61677-01A1.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Physiology,
7756, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900. Tel.: 210-567-4401; Fax:
210-567-4410; E-mail: firullia@UTHSCSA.edu.
Published, JBC Papers in Press, August 2, 2000, DOI 10.1074/jbc.M005888200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: bHLH, basic helix-loop-helix; PCR, polymerase chain reaction; En, embryonic day n; GST, glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis; MCK, muscle creatine kinase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Lee, J. E. (1997) Curr. Opin. Neurobiol. 7, 13-20 |
| 2. | Molkentin, J. D., and Olson, E. N. (1996) Curr. Opin. Genet. Dev. 6, 445-453 |
| 3. | Olson, E. N., and Klein, W. H. (1994) Genes Dev. 8, 1-8 |
| 4. | Hu, J. S., Olson, E. N., and Kingston, R. E. (1992) Mol. Cell. Biol. 12, 1031-1042 |
| 5. | Neuman, T., Keen, A., Knapik, E., Shain, D., Ross, M., Nornes, H. O., and Zuber, M. X. (1993) Eur. J. Neurosci. 5, 311-318 |
| 6. | Olson, E. N., and Klein, W. H. (1994) Genes Dev. 8, 1-8 |
| 7. | Chakraborty, T., Brennan, T. J., Li, L., Edmondson, D., and Olson, E. N. (1991) Mol. Cell. Biol. 11, 3633-3641 |
| 8. | Staudinger, J., Perry, M., Elledge, S. J., and Olson, E. N. (1993) J. Biol. Chem. 268, 4608-4611 |
| 9. | Cserjesi, P., Brown, D., Lyons, G. E., and Olson, E. N. (1995) Dev. Biol. 170, 664-678 |
| 10. | Hollenberg, S. M., Sternglanz, R., Cheng, P. F., and Weintraub, H. (1995) Mol. Cell. Biol. 15, 3813-3822 |
| 11. | Cross, J. C., Flannery, M. L., Blanar, M. A., Steingrimsson, E., Jenkins, N. A., Copeland, N. G., Rutter, W. J., and Werb, Z. (1995) Development 121, 2513-2523 |
| 12. | Srivastava, D., Cserjesi, P., and Olson, E. N. (1995) Science 270, 1995-1999 |
| 13. | Firulli, A. B., McFadden, D. G., Lin, Q., Srivastava, D., and Olson, E. N. (1998) Nat. Genet. 18, 266-270 |
| 14. | Srivastava, D., Thomas, T., Lin, Q., Kirby, M. L., Brown, D., and Olson, E. N. (1997) Nat. Genet 16, 154-160 |
| 15. | Riley, P., Anson-Cartwright, L., and Cross, J. C. (1998) Nat Genet 18, 271-275 |
| 16. | Nakagawa, O., Nakagawa, M., Richardson, J. A., Olson, E. N., and Srivastava, D. (1999) Dev. Biol. 216, 72-84 |
| 17. | Kokubo, H., Lun, Y., and Johnson, R. L. (1999) Biochem. Biophys. Res. Commun. 260, 459-465 |
| 18. | Steidl, C., Leimeister, C., Klaunt, B., Maier, M., Nanda, I., Dixon, D., Clarke, R., Schmid, M., and M., G. (2000) Genomics 66, 195-203 |
| 19. | Xin, X. Q., Nelson, C., Collins, L., and Dorshkind, K. (1993) Journal of Immunology 151, 5398-5407 |
| 20. | Staub, O., Dho, S., Henry, P., Correa, J., Ishikawa, T., McGlade, J., and Rotin, D. (1996) EMBO J. 15, 2371-2380 |
| 21. | Dobrosotskaya, I., Guy, R. K., and James, G. L. (1997) J. Biol. Chem. 272, 31589-31597 |
| 22. | James, P., Halladay, J., and Craig, E. A. (1996) Genetics 144, 1425-1436 |
| 23. | Smith, D. B., and Johnson, K. S. (1988) Gene (Amst.) 67, 31-40 |
| 24. | Rhodes, K. J., Monaghan, M. M., Barrezueta, N. X., Nawoschik, S., Bekele-Arciri, Z., Matos, M. F., Nakahira, K., Schechter, L. E., and Trimmer, J. S. (1996) J. Neurosci. 16, 4846-4860 |
| 25. | Molkentin, J. D., Firulli, A. B., Black, B. L., Martin, J. F., Hustad, C. M., Copeland, N., Jenkins, N., Lyons, G., and Olson, E. N. (1996) Mol. Cell. Biol. 16, 3814-3824 |
| 26. | Lemcercier, C., To, R. Q., Carrasco, K., and Kinieczny, S. F. (1998) EMBO J. 17, 1412-1422 |
| 27. | Charite, J., McFadden, D. G., and Olson, E. N. (2000) Development 127, 2461-2470 |
| 28. | Fernandez-Teran, M., Piedra, M. E., Kathiriya, I. S., Srivastava, D., Rodriguez-Rey, J. C., and Ros, M. A. (2000) Development 127, 2133-2142 |
| 29. | Yelon, D., Ticho, B., Halpern, M. E., Ruvinsky, I., Ho, R. K., Silver, L. M., and Stainier, D. Y. R. (2000) Development 127, 2573-2582 |
| 30. | Scott, I. C., Anson-Cartwright, L., RIiley, P., Reda, D., and Cross, J. C. (2000) Mol. Cell. Biol. 20, 530-541 |
| 31. | Olson, E. N., and Srivastava, D. (1996) Science 272, 671-676 |
| 32. | Massari, M. E., and Murre, C. (2000) Mol. Cell. Biol. 20, 429-440 |
| 33. | Lewis, A. L., Xia, Y., Datta, S. K., McMillin, J., and Kellems, R. E. (1999) J. Biol. Chem. 274, 14188-14197 |
| 34. | Blackwell, T. K., and Weintraub, H. (1990) Science 250, 1104-1110 |
| 35. | Writght, W. E., Binder, M., and Funk, W. (1991) Mol. Cell. Biol. 11, 4101-4110 |
| 36. | Ishibashi, M., Ang, S. L., Shiota, K., Nakanishi, S., Kageyama, R., and Guillemot, F. (1995) Genes Dev. 9, 3136-3148 |
This article has been cited by other articles:
![]() |
Y. Oma, Y. Kino, K. Toriumi, N. Sasagawa, and S. Ishiura Interactions between homopolymeric amino acids (HPAAs) Protein Sci., October 1, 2007; 16(10): 2195 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Firulli, B. A. Redick, S. J. Conway, and A. B. Firulli Mutations within Helix I of Twist1 Result in Distinct Limb Defects and Variation of DNA Binding Affinities J. Biol. Chem., September 14, 2007; 282(37): 27536 - 27546. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fischer and M. Gessler Delta Notch and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors Nucleic Acids Res., July 14, 2007; 35(14): 4583 - 4596. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Risebro, N. Smart, L. Dupays, R. Breckenridge, T. J. Mohun, and P. R. Riley Hand1 regulates cardiomyocyte proliferation versus differentiation in the developing heart Development, November 15, 2006; 133(22): 4595 - 4606. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fuke, N. Sasagawa, and S. Ishiura Identification and Characterization of the Hesr1/Hey1 as a Candidate trans-Acting Factor on Gene Expression through the 3' Non-Coding Polymorphic Region of the Human Dopamine Transporter (DAT1) Gene J. Biochem., February 1, 2005; 137(2): 205 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ninkovic, A. Tallafuss, C. Leucht, J. Topczewski, B. Tannhauser, L. Solnica-Krezel, and L. Bally-Cuif Inhibition of neurogenesis at the zebrafish midbrain-hindbrain boundary by the combined and dose-dependent activity of a new hairy/E(spl) gene pair Development, January 1, 2005; 132(1): 75 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Hill and P. R. Riley Differential Regulation of Hand1 Homodimer and Hand1-E12 Heterodimer Activity by the Cofactor FHL2 Mol. Cell. Biol., November 15, 2004; 24(22): 9835 - 9847. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wilson-Rawls, J. M. Rhee, and A. Rawls Paraxis Is a Basic Helix-Loop-Helix Protein That Positively Regulates Transcription through Binding to Specific E-box Elements J. Biol. Chem., September 3, 2004; 279(36): 37685 - 37692. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dodou, M. P. Verzi, J. P. Anderson, S.-M. Xu, and B. L. Black Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development Development, August 15, 2004; 131(16): 3931 - 3942. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Rychlik, V. Gerbasi, and E. J. Lewis The Interaction between dHAND and Arix at the Dopamine {beta}-Hydroxylase Promoter Region Is Independent of Direct dHAND Binding to DNA J. Biol. Chem., December 5, 2003; 278(49): 49652 - 49660. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lavoie, F. Debeane, Q.-D. Trinh, J.-F. Turcotte, L.-P. Corbeil-Girard, M.-J. Dicaire, A. Saint-Denis, M. Page, G. A. Rouleau, and B. Brais Polymorphism, shared functions and convergent evolution of genes with sequences coding for polyalanine domains Hum. Mol. Genet., November 15, 2003; 12(22): 2967 - 2979. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Dai, P. Cserjesi, B. E. Markham, and J. D. Molkentin The Transcription Factors GATA4 and dHAND Physically Interact to Synergistically Activate Cardiac Gene Expression through a p300-dependent Mechanism J. Biol. Chem., June 28, 2002; 277(27): 24390 - 24398. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Dai and P. Cserjesi The Basic Helix-Loop-Helix Factor, HAND2, Functions as a Transcriptional Activator by Binding to E-boxes as a Heterodimer J. Biol. Chem., April 5, 2002; 277(15): 12604 - 12612. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. te Welscher, M. Fernandez-Teran, M. A. Ros, and R. Zeller Mutual genetic antagonism involving GLI3 and dHAND prepatterns the vertebrate limb bud mesenchyme prior to SHH signaling Genes & Dev., February 15, 2002; 16(4): 421 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. McFadden, J. McAnally, J. A. Richardson, J. Charite, and E. N. Olson Misexpression of dHAND induces ectopic digits in the developing limb bud in the absence of direct DNA binding Development, January 7, 2002; 129(13): 3077 - 3088. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Cross, L. Anson-Cartwright, and I. C. Scott Transcription Factors Underlying the Development and Endocrine Functions of the Placenta Recent Prog. Horm. Res., January 1, 2002; 57(1): 221 - 234. [Abstract] [Full Text] [PDF] |
||||
| ||||||||